Predictors of prolonged progression-free survival in patients with unresectable or recurrent pancreatic cancer treated with nanoliposomal irinotecan with fluorouracil and folinic acid (NAPOLEON-2 study). - Kawaguchi Y; Hayashi K; Shimokawa M; Otsuka T; Nakazawa J; Shimokawa H; Shinohara Y; Koga F; Oza N; Oda H; Takeshita S; Arima S; et al. (Therapeutic advances in medical oncology, 2026)